FDA Inspection 1122366 — Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
The FDA completed an inspection of Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit on Mar 12, 2020 in Amman. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amman (Jordan)
Additional details
Clinical BA/BE